Search

Displaying results 9621 - 9630 of 10000 in total
  1. Drug

    Cucurbita pepo subsp. ovifera whole

    go.drugbank.com/drugs/DB15592
    Approved

    Cucurbita pepo subsp. ovifera whole allergenic extract is used in allergenic testing.

  2. Drug

    Acoltremon

    go.drugbank.com/drugs/DB19202
    ApprovedInvestigational

    Acoltremon is under investigation in clinical trial NCT05493111 (A Long-term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512).

    Synonyms: N-(4-methoxyphenyl)-p-menthanecarboxamide, Cyclohexanecarboxamide, n-(4-methoxyphenyl)-5-methyl-2-(1-methylethyl)-, (1r,2s,5r)-
  3. Drug

    Lorcainide

    go.drugbank.com/drugs/DB13653
    Experimental

    Categories: Antiarrhythmics, Class I, Antiarrhythmics, Class Ic
  4. Drug

    Rebaudioside A

    go.drugbank.com/drugs/DB15136
    Investigational

    Rebaudioside A is under investigation in clinical trial NCT03510624 (Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus).

  5. Drug

    Mesulergine

    go.drugbank.com/drugs/DB21193
    Experimental

    Mesulergine is a small molecule drug. Mesulergine has a monoisotopic molecular weight of 362.18 Da.

    Categories: Heterocyclic Compounds with 4 or More Rings
  6. Drug

    Aclarubicin

    go.drugbank.com/drugs/DB11617
    Investigational

    Categories: Topoisomerase II Inhibitors
  7. Drug

    Obicetrapib

    go.drugbank.com/drugs/DB14890
    Investigational

    Obicetrapib is under investigation in clinical trial NCT02241772 (A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)).

  8. Drug

    Chlormadinone

    go.drugbank.com/drugs/DB13528
    Investigational

    Categories: Hormonal Contraceptives for Systemic Use
  9. Drug

    Bimosiamose

    go.drugbank.com/drugs/DB06197
    Investigational

  10. Drug

    SCB-2019

    go.drugbank.com/drugs/DB15805
    Investigational

    As of June 2020, the company is pursuing a randomized, double blind, placebo controlled study (NCT04405908) to test the safety and immunogenicity of the vaccine. … SCB-2019 is a recombinant trimeric S protein subunit vaccine candidate being investigated against COVID-19.